Routine board addition with no strategic or operational signal. The option grant represents modest dilution (~57K shares vs ~80M+ outstanding). No immediate trading catalyst — monitor for any future committee assignments or strategic moves.
Price Chart
Executive Summary
Dyne Therapeutics elected Barry E. Greene as an independent Class I director to its board. This is a routine board appointment with standard compensation under the non-employee director program — no material financial or strategic impact.
Key Facts
- Barry E. Greene elected as Class I director effective June 22, 2026
- Not appointed to any board committees
- Received option to purchase 57,463 shares at $20.87 per share, vesting over 3 years
- Annual cash compensation of $45,000 as board member
- No family relationships or transactions with existing directors/officers
Financial Impact
Standard non-employee director compensation — option grant valued at ~$1.2M at grant price, annual cash retainer $45,000
Risk Factors
- No material risk — standard director appointment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001818794-26-000005 |
| Document: 0001818794-26-000005-index-headers.html | 0001818794-26-000005 |
| Document: 0001818794-26-000005-index.html | 0001818794-26-000005 |
| Document: 0001818794-26-000005.txt | 0001818794-26-000005 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access